Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery

Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery

ObjectiveThis study aimed to develop prognostic prediction models for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction (AEG) who received neoadjuvant therapy (neoadjuvant chemoradiotherapy or neoadjuvant chemotherapy) and radical surgery. A baseline nomogram and a pos...

Full description

Bibliographic Details
Main Authors: Zhenjiang Guo, Honghai Guo, Yuan Tian, Ze Zhang, Qun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
nomogram
disease-free survival
neoadjuvant radiotherapy
prognosis
esophagogastric junction adenocarcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.908229/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.908229/full

Similar Items